How much funding has PROTEGO BIOPHARMA, INC. raised?

PROTEGO BIOPHARMA, INC. has raised $181.0M in total funding, most recently a series b round.

Who are PROTEGO BIOPHARMA, INC.'s investors?

PROTEGO BIOPHARMA, INC.'s investors include Novartis Venture Fund, Forbion Capital Partners, Omega Funds, Droia Ventures, YK Bioventures, Digitalis Ventures.

When was PROTEGO BIOPHARMA, INC. founded?

PROTEGO BIOPHARMA, INC. was founded in 2018.

Where is PROTEGO BIOPHARMA, INC. headquartered?

PROTEGO BIOPHARMA, INC. is headquartered in SAN DIEGO, California, United States.

What industry is PROTEGO BIOPHARMA, INC. in?

PROTEGO BIOPHARMA, INC. operates in Biotech, Healthcare.

How many employees does PROTEGO BIOPHARMA, INC. have?

PROTEGO BIOPHARMA, INC. has 11-50 employees.

PROTEGO BIOPHARMA, INC.

Home - Protego

SAN DIEGO, United States · Founded 2018 · $181.0M raised

Biotech

Healthcare

Headquarters: SAN DIEGO, California
Employees: 11–50
Founded: 2018
Business Model: B2B

Website: protegobiopharma.com
Total Funding: $181.0M
Last Round: $130.0M Series BJan 2025
Rounds: 2

About

Protego Biopharma is a San Diego-based biotech company developing first-in-class small molecule therapeutics that target protein misfolding diseases. Using a pharmacological chaperone approach, the company aims to reprogram protein folding to treat rare and systemic diseases including AL amyloidosis, myopathy, and cardiomyopathy. PROT-001 is advancing toward a pivotal clinical trial backed by $181M in total financing.

Summary

PROTEGO BIOPHARMA, INC. is a Biotech company based in SAN DIEGO, United States, founded in 2018. It has raised $181.0M in total across 2 rounds, most recently a $130.0M Series B round in Jan 2025. Investors include Novartis Venture Fund, Forbion Capital Partners and Omega Funds.